Pharmaceuticals (Jan 2023)

Stabilization of Acne Vulgaris-Associated Microbial Dysbiosis with 2% Supramolecular Salicylic Acid

  • Hazrat Bilal,
  • Yuanyuan Xiao,
  • Muhammad Nadeem Khan,
  • Jinyu Chen,
  • Qian Wang,
  • Yuebin Zeng,
  • Xinyu Lin

DOI
https://doi.org/10.3390/ph16010087
Journal volume & issue
Vol. 16, no. 1
p. 87

Abstract

Read online

Facial microbiota dysbiosis is an important factor in causing acne vulgaris. The present study aimed to analyze the effect of 2% Supramolecular Salicylic Acid (SSA) on acne-associated facial bacteria. In the current study, 30 acne vulgaris patients (treated with 2% SSA for eight weeks) and ten volunteers with no facial acne were selected. Samples from acne patients (before and after treatment) and volunteers (not treated) were analyzed via high throughput sequencing, Deblur algorithm, and R microbiome package. After treatment with 2% SSA, the total lesion count and global acne grading system (GAGS) score reduced significantly (p p Staphylococcus, Ralstonia, and Streptococcus. The proportion of these three genera was significantly decreased in the post-treated group, and overall bacteria genera distribution tends toward the healthy individual. It is concluded that 2% SSA normalizes the microbial communities associated with the skin.

Keywords